UK Watchdog Accuses Merck Of Arthritis Drug Scheme

The U.K.'s Competition and Markets Authority provisionally found Tuesday that pharmaceutical company Merck Sharp & Dohme Ltd. has operated an anti-competitive discount scheme for its popular brand-name arthritis medicine Remicade in...

Already a subscriber? Click here to view full article